ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
16.95765
-0.19%
Brent Oil
81.02
0.27%
Bitcoin
68,551.80
1.19%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Collegium Pharmaceutical Inc (COLL)

  7. Collegium Pharmaceutical Inc (COLL) Noticias

COLL Collegium Pharmaceutical Inc

33.14
0.71 (2.19%)
31 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Collegium Pharmaceutical Inc COLL NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.71 2.19% 33.14 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
32.64 32.255 33.50 33.14 32.43
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/5/202412:11EDGAR2Form 144 - Report of proposed sale of securities
29/5/202410:19EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
29/5/202409:05EDGAR2Form 144 - Report of proposed sale of securities
29/5/202407:00GLOBECollegium to Participate in Jefferies Global Healthcare..
28/5/202415:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202411:12EDGAR2Form 144 - Report of proposed sale of securities
28/5/202409:05EDGAR2Form 144 - Report of proposed sale of securities
24/5/202415:05EDGAR2Form 8-K - Current report
24/5/202412:01EDGAR2Form 144 - Report of proposed sale of securities
23/5/202415:22EDGAR2Form 144 - Report of proposed sale of securities
20/5/202415:05EDGAR2Form 8-K - Current report
16/5/202418:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202418:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202418:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202418:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202418:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202418:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202418:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202407:05EDGAR2Form 8-K - Current report
13/5/202407:00GLOBECollegium Announces $35 Million Accelerated Share Repurchase..
10/5/202407:03EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/5/202407:02EDGAR2Form 8-K - Current report
09/5/202415:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202415:02GLOBECollegium Reports First Quarter 2024 Financial Results
09/5/202415:01GLOBECollegium Announces CEO Transition
29/4/202407:00GLOBECollegium Announces Authorized Generic Agreement with Hikma..
25/4/202407:00GLOBECollegium to Report First Quarter 2024 Financial Results on..
11/4/202407:00GLOBECollegium Pharmaceutical, Inc. Announces Redemption of..
03/4/202407:00GLOBECollegium to Participate in 23rd Annual Needham Virtual..
04/3/202415:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202416:24EDGAR2Form 144 - Report of proposed sale of securities
26/2/202415:39EDGAR2Form 144 - Report of proposed sale of securities
22/2/202415:09GLOBECollegium Reports Record Fourth Quarter and Full-Year 2023..
22/2/202415:03EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202415:01EDGAR2Form 8-K - Current report
14/2/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202415:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202415:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202415:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202415:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202411:04EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202407:00GLOBECollegium to Report Fourth Quarter and Full-Year 2023..
18/1/202415:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202415:20EDGAR2Form 144 - Report of proposed sale of securities
03/1/202407:03EDGAR2Form 8-K - Current report
03/1/202407:00GLOBECollegium Provides 2024 Financial Guidance
22/12/202315:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202315:15EDGAR2Form 144 - Report of proposed sale of securities
20/12/202316:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202315:28EDGAR2Form 144 - Report of proposed sale of securities

Su Consulta Reciente

NASDAQ
COLL
Collegium Pharmaceutical
LSE
71CJ
Westpac 28
LSE
54XC
Int.fin. 46
LSE
SYM
Symphony Environmental T...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados